Dr. Husain Attarwala is an accomplished clinical pharmacologist, pharmacometrician and researcher in drug development for genetic medicines. He is presently the Vice President and Head of DMPK, Clinical Pharmacology and Pharmacometrics at Aera Therapeutics. Prior to this, he was serving as the Sr. Director and Head of Clinical Pharmacology and Pharmacometrics at Moderna, where his research focused on developing predictive models to aid clinical dose decisions for mRNA vaccines and therapeutics. Before that, he was a Principal Scientist at Alnylam Pharmaceuticals, where his research contributed to the selection of doses for various novel siRNA therapeutics, five of which have obtained global regulatory approval. He holds a PhD and MS in Pharmaceutical Sciences and Drug Delivery Systems from Northeastern University and a Bachelors in Pharmacy from Al-Ameen College of Pharmacy.